Blog #1: Introduction
Blog #2: Chronic Inflammation-the basis of "all" diseases?
Blog #3: Stress-the cause of "all" immune responses
Blog #4: Bias of the female v. male immune system
Blog #5: The innate (aka "natural") immune system & immunity
Blog #6: Evolutionary development of the immune system (Part 1)
Blog #7: Evolutionary development of the immune system (Part 2)
Blog #8: Embryology and pregnancy related to the immune system
Blog #9: The adaptive (aka “acquired”) immune system: from friend to foe
Blog #10: Immunogenetics and Immunogenomics
Blog #11: The Human Genome Project (HGP), Precision medicine, and "AIl of Us"
Blog #12: XCI (lyonization)
Blog #13:The Microbiome: "Gut-axis-du jour"
Blog #14:Chronic inflammation- “Enemy #1” (Part 1: Etiologies and pathogenesis)
Blog #15:Chronic inflammation (CI)- “Enemy #1” (Part 2: Pharmacology and pharmacodynamics
Blog #16:Chronic inflammation (CI)- “Enemy #1” (Part 3: A multisystem pathology)
Blog #17: Neuroimmunology
Blog #18:Autoimmune disease (Part 1) - Etiologies
Blog #19: Autoimmune disease (Part 2)- Female bias)
Blog #20: Autoimmune disease (Part 3)- Clinical considerations)
Blog #21: Immunotherapeutics (Monoclonal antibodies, biosilimars biologics and small molecule drugs)
Blog #22: Immunotherapeutic procedures (PART 1: Stem cell transplantation therapy)
Blog #23: Immunotherapeutic procedures (Part 2: Homograph transplantation)
Blog #24: Immunotherapeutic procedures (Part 3: Genetic engineering/ modifications)
Blog #25: Immunotherapeutic procedures (Part 4: CAR-T & CAAR-T cell therapy)
Blog #26: Immunotherapeutic procedures (Part 5: CRISPR-Cas9 therapy)
Blog #27: Cancer (Part 1)- Epidemiology
Blog #28: Cancer (Part 2) - Etiologies
Blog #29: Cancer (Part 3)- Microbiome, XCI, and microRNA
Blog #30: Cancer (Part 4) -Clinical considerations & diagnosis
Blog #31: Cancer treatment (Part 1)- Chemotherapy, Radiation & Molecular targeted therapy
Blog #32: Cancer treatment (Part 2)-Immunotherapeutics, Cellular & Genetic procedures
Blog #33: Cancer treatment (Part 3)- Idiotype-anti-idiotype Regulatory Circuit or Loop
Blog #34: Cancer treatment (Part 4)- Combination strategies in cancer immunotherapy
Blog #35: Immunology’s role in infectious disease (Part 1: Pathogenesis)
Blog #36: Immunology’s role in pandemics, infectious disease, and COVID-19 (Part 2: Genetics)
Blog #37: Immunology’s role in pandemics, infectious disease, and COVID-19 (Part 3: Clinical)
Blog #38: Immunology’s role in pandemics, infectious disease, and COVID-19 (Part 4: Therapy)
Blog #39: Immunology’s role in pandemics, infectious disease, and COVID-19 (Part 5: Immunotherapies)
Blog #40: Immunology’s role in pandemics, infectious disease, and COVID-19 (Part 6: Anti-virals)
Blog #41: Immunology’s role in pandemics, infectious disease, and COVID-19 (Part 7: Vaccines)
Blog #42: Immunology’s role in pandemics, infectious disease, and COVID-19 (Part 8: Vaccination)
Blog #43: Immunoinformatics & epidemiological considerations in COVID-19
Blog #44: Immunology’s role in public health considerations and recommendations
Blog #45: Epilogue